Aclid logo — Helping scientists build safer and better biomanufactured pr...

Aclid

Helping scientists build safer and better biomanufactured products

Founded 2021 United States New York, United States 15 employees Seed Total: $3.30M Biopharma, Biotechnology +1

General Information

Company Name Aclid
Founded Year 2021
Location United States New York, United States +1
Employees 15
Industries Biopharma, Biotechnology, Life Sciences
Funding Stage Seed
Social

Get notified when Aclid moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aclid

Aclid, founded in 2021, is positioned as a critical player in the Biopharma, Biotechnology, and Life Sciences sectors. Its platform enhances biosecurity and biosafety, ensuring efficient lab operations and compliance in environmental, health, and safety standards. Aclid's solutions are already trusted by leading life sciences companies and government bodies seeking responsible research methodologies.

Headquartered in the United States, Aclid recently secured a $3.30M seed investment led by 2048 Ventures and IA Ventures as of 01 October 2023. This financial boost underscores investor confidence in Aclid's ability to innovate and solve critical issues within the scientific community.

Overall, Aclid represents a promising opportunity for investors seeking to support and scale a company that is not only poised for growth but also essential for advancing safety in biomanufacturing processes.

Taxonomy: biotechnology security, compliance automation, biosafety, biosecurity, lab operations, EH&S (Environmental Health and Safety), quality monitoring, gene synthesis verification, pathogen screening, DNA screening, RNA screening, compliance inspections, life sciences compliance, biomanufacturing safety, biotechnology risk management

Services & Products

Automated Biosecurity and Biosafety Compliance
Real-time Threat and Risk Profiling
Sanctions and Watchlist Screening
Collaborative Compliance Data Management
Advanced Sequence and Construct Analysis
Customer Assessment Automation

Target Customers

Biotechnology Companies Research Institutions Biosecurity Professionals Compliance Officers Laboratories Security Teams

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• 2
Investor Investor
01 Oct 2023
Seed •••••• 2
Investor Investor
01 Oct 2021

Aclid Alternatives & Competitors

View All Alternatives
Aclid vs
Zxerex Corporation
Zxerex Corporation United States

Patented science-based workplace safety solutions. Screen for impairment THC/Fatigue or deploy pande...

4 employees
Biotechnology
Aclid vs

HC&A has effectively reduced workplace exposures through improved safety cultures for over 25 years.

20 employees
Aclid vs

Be In Compliance With The Best!

19 employees

FAQ About Aclid

Helping scientists build safer and better biomanufactured products
Aclid was founded in 2021.
Aclid is headquartered in New York, United States.
Aclid operates in the following industries: Biopharma, Biotechnology, Life Sciences.
Aclid has approximately 15 employees.
Aclid has completed 2 funding rounds, raising a total of $3.30M. The latest funding stage is Seed.
Aclid offers: Automated Biosecurity and Biosafety Compliance, Real-time Threat and Risk Profiling, Sanctions and Watchlist Screening, Collaborative Compliance Data Management, Advanced Sequence and Construct Analysis, Customer Assessment Automation.
Top alternatives and competitors to Aclid include Zxerex Corporation, Hettrick, Cyr & Associates, Drug & Alcohol Testing Compliance Services, ScreeningOne, TPS Alert. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aclid and Zxerex Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aclid and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy